Cryo-EM structure of the ATP11C Q79E mutant reveals the structural basis for altered Phospholipid recognition
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2025.110935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Yuheng Qian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Hokkaido University, Japan; Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan. Hauptthemen laut MEDLINE: Adenosine Triphosphatases, Phospholipids, Mutation, Missense. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Closely related P4-ATPases, ATP11A and ATP11C, act as major phospholipid flippases in the plasma membrane of mammalian cells, with strict substrate specificity for phosphatidylserine (PS) and phosphatidylethanolamine (PE), but not for phosphatidylcholine (PC), thereby contributing to the asymmetric distribution of PS and PE across bilayers. A previously reported disease-associated Q84E mutation in ATP11A confers the ability to flip PC, implicating the involvement of this conserved residue in substrate specificity. We performed cryo-EM analysis for the equivalent mutant Q79E of ATP11C to address the structural basis for its unusual substrate specificity. Measurement of ATPase activity revealed that the ATP11C Q79E mutant retained PS-dependent activity, whilst gaining robust PC-dependent activity, indicative of expanded substrate specificity, consistent with reported properties in ATP11A Q84E. The cryo-EM structure of ATP11C Q79E mutant in the PC-occluded E2-Pi state revealed a PC molecule in a reshaped binding pocket. Due to the Q79E mutation and associated conformational changes in its surrounding residues, including Ser91and Asn352, the binding pocket has additional space to accommodate the bulky choline headgroup. Our results provide structural and functional insights into how a single point mutation can alter substrate specificity in a P4-ATPase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Hokkaido University, Japan; Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
- Department of Chemistry, Faculty of Science, Hokkaido University, Japan; RIKEN SPring-8 Center, Sayo-gun, Hyogo, Japan.
- RIKEN SPring-8 Center, Sayo-gun, Hyogo, Japan.
- Japan Synchrotron Radiation Research Institute (JASRI), Sayo, Hyogo, Japan.
- Department of Chemistry, Faculty of Science, Hokkaido University, Japan. Electronic address: kabe@sci.hokudai.ac.jp.
- Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan; Cellular and Structural Physiology Institute (CeSPI), Nagoya University, Nagoya, Japan; Institute for Glyco-core Research (iGCORE), Nagoya Un…
Förderung
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Qian, Y., Gopalasingam, C. C., Gerle, C., Shigematsu, H., Abe, K., & Oshima, A. (2026). Cryo-EM structure of the ATP11C Q79E mutant reveals the structural basis for altered Phospholipid recognition. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110935
Vancouver
Qian Y, Gopalasingam CC, Gerle C, Shigematsu H, Abe K, Oshima A. Cryo-EM structure of the ATP11C Q79E mutant reveals the structural basis for altered Phospholipid recognition. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.110935
BibTeX
@article{Qian2026,
author = {Qian, Yuheng and Gopalasingam, Chai C and Gerle, Christoph and Shigematsu, Hideki and Abe, Kazuhiro and Oshima, Atsunori},
title = {Cryo-EM structure of the ATP11C Q79E mutant reveals the structural basis for altered Phospholipid recognition},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2025.110935}
}
EUVIMED